The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ElinavENowarskiRThaissCAHuBJinCFlavellRAInflammation-induced cancer: crosstalk between tumours, immune cells and microorganismsNat Rev Cancer2013131175977124154716
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• DemariaSPikarskyEKarinMCancer and inflammation: promise for biologic therapyJ Immunother201033433535120386472
   PubMed Web of Science ®Google Scholar
• GambhirSVyasDHollisMAekkaAVyasANuclear factor kappa B role in inflammation associated gastrointestinal malignanciesWorld J Gastroenterol201521113174318325805923
   PubMed Web of Science ®Google Scholar
• SchutteKBornscheinJMalfertheinerPHepatocellular carcinoma – epidemiological trends and risk factorsDig Dis20092728092
   PubMed Web of Science ®Google Scholar
• RoxburghCSMcMillanDCRole of systemic inflammatory response in predicting survival in patients with primary operable cancerFuture Oncol20106114916320021215
   PubMed Web of Science ®Google Scholar
• PinatoDJStebbingJIshizukaMA novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)J Hepatol20125751013102022732513
   PubMed Web of Science ®Google Scholar
• TianWZhaoYLiuSLiXMeta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancerEur J Cancer Prev201019428829820386312
   PubMed Web of Science ®Google Scholar
• WangXLinYWWuJMeta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer riskWorld J Surg Oncol20141230425282624
   PubMed Web of Science ®Google Scholar
• AndersenVVogelUSystematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancerAliment Pharmacol Ther201440214715924889212
   PubMedGoogle Scholar
• CorleyDAKerlikowskeKVermaRBufflerPProtective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysisGastroenterology20031241475612512029
   PubMed Web of Science ®Google Scholar
• TakkoucheBRegueira-MendezCEtminanMBreast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysisJ Natl Cancer Inst2008100201439144718840819
   PubMedGoogle Scholar
• ZhangHJiangDLiXUse of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studiesPLoS One201387e7000823894577
   PubMedGoogle Scholar
• TangLHuHLiuHJianCWangHHuangJAssociation of non-steroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studiesOncotarget2016740651966520727533449
   PubMedGoogle Scholar
• GuoZJiangJHZhangJCOX-2 promotes migration and invasion by the side population of cancer stem cell-like hepatocellular carcinoma cellsMedicine (Baltimore)20159444e180626554780
   PubMed Web of Science ®Google Scholar
• GreenlandSQuantitative methods in the review of epidemiologic literatureEpidemiol Rev198791303678409
   PubMed Web of Science ®Google Scholar
• LiuFYanLWangZMetformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: a systematic review and meta-analysisOncotarget201789160171602627926481
   PubMedGoogle Scholar
• CooganPFRosenbergLPalmerJRNonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowelCancer Epidemiol Biomarkers Prev20009111912310667472
   PubMed Web of Science ®Google Scholar
• ChiuHFHoSCChenCCYangCYStatin use and the risk of liver cancer: a population-based case-control studyAm J Gastroenterol2011106589489821157439
   PubMed Web of Science ®Google Scholar
• JacobsEJNewtonCCGapsturSMThunMJDaily aspirin use and cancer mortality in a large US cohortJ Natl Cancer Inst2012104161208121722888140
   PubMed Web of Science ®Google Scholar
• SahasrabuddheVVGunjaMZGraubardBINonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinomaJ Natl Cancer Inst2012104231808181423197492
   PubMedGoogle Scholar
• PetrickJLSahasrabuddheVVChanATNSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling projectCancer Prev Res (Phila)20158121156116226391917
   PubMed Web of Science ®Google Scholar
• YangBPetrickJLChenJAssociations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research DatalinkCancer Epidemiol20164310511127420633
   PubMed Web of Science ®Google Scholar
• KimGJangSYHanEEffect of statin on hepatocellular carcinoma in patients with type 2 diabetes: a nationwide nested case-control studyInt J Cancer2017140479880627861855
   PubMed Web of Science ®Google Scholar
• WuCYChenYJHoHJAssociation between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resectionJAMA2012308181906191423162861
   PubMed Web of Science ®Google Scholar
• YehCCLinJTJengLBNonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a nationwide cohort studyAnn Surg2015261352152624950265
   PubMed Web of Science ®Google Scholar
• TakamiYEguchiSTateishiMA randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatmentHepatol Int201610579980626846471
   PubMed Web of Science ®Google Scholar
• LeePCYehCMHuYWAntiplatelet therapy is associated with a better prognosis for patients with hepatitis B virus-related hepatocellular carcinoma after liver resectionAnn Surg Oncol201623Suppl 587488327541812
   PubMedGoogle Scholar
• LiJHWangYXieXYAspirin in combination with TACE in treatment of unresectable HCC: a matched-pairs analysisAm J Cancer Res2016692109211627725915
   PubMed Web of Science ®Google Scholar
• SuCHepatobiliary cancer: all efforts for one goalCancer Lett2016379216416527054486
   PubMedGoogle Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
   PubMed Web of Science ®Google Scholar
• LaineAIyengarPPanditaTKThe role of inflammatory pathways in cancer-associated cachexia and radiation resistanceMol Cancer Res201311996797223788634
   PubMed Web of Science ®Google Scholar
• BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
   PubMed Web of Science ®Google Scholar
• AllinKHBojesenSENordestgaardBGInflammatory biomarkers and risk of cancer in 84,000 individuals from the general populationInt J Cancer201613971493150027194008
   PubMed Web of Science ®Google Scholar
• AleksandrovaKBoeingHNothlingsUInflammatory and metabolic biomarkers and risk of liver and biliary tract cancerHepatology201460385887124443059
   PubMed Web of Science ®Google Scholar
• CervelloMMontaltoGCyclooxygenases in hepatocellular carcinomaWorld J Gastroenterol200612325113512116937518
   PubMed Web of Science ®Google Scholar
• CoffeltSBde VisserKECancer: inflammation lights the way to metastasisNature20145077490484924572360
   PubMed Web of Science ®Google Scholar
• RamakrishnaGRastogiATrehanpatiNSenBKhoslaRSarinSKFrom cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescenceLiver Cancer201323–436738324400224
   PubMed Web of Science ®Google Scholar
• SubramaniamAShanmugamMKPerumalEPotential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinomaBiochim Biophys Acta201318351466023103770
   PubMed Web of Science ®Google Scholar
• SmithWLGaravitoRMDeWittDLProstaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2J Biol Chem19962715233157331608969167
   PubMed Web of Science ®Google Scholar
• ChanATOginoSFuchsCSAspirin and the risk of colorectal cancer in relation to the expression of COX-2N Engl J Med2007356212131214217522398
   PubMed Web of Science ®Google Scholar
• SciulliMGSetaFTacconelliSEffects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cellsBr J Pharmacol2003138463464112598417
   PubMed Web of Science ®Google Scholar
• NagaoMSatoYYamauchiAA meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancerPLoS One201388e7112623967159
   PubMedGoogle Scholar
• ChalasaniNHorlanderJCSrSaidAScreening for hepatocellular carcinoma in patients with advanced cirrhosisAm J Gastroenterol199994102988299310520857
   PubMedGoogle Scholar
• BreinigMRiekerREiteneuerEDifferential expression of E-prostanoid receptors in human hepatocellular carcinomaInt J Cancer2008122354755717918156
   PubMedGoogle Scholar
• YangHJJiangJHYangYTCyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survivalWorld J Gastroenterol201622398798880527818595
   PubMedGoogle Scholar
• ChenGLiXYangJPrognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysisArch Med Sci20161251110111727695503
   PubMedGoogle Scholar
• LampiasiNFoderaDD’AlessandroNThe selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cellsInt J Mol Med200617224525216391822
   PubMedGoogle Scholar
• GoubranHAStakiwJRadosevicMBurnoufTPlatelet–cancer interactionsSemin Thromb Hemost201440329630524590421
   PubMedGoogle Scholar
• JabenEAMulaySBStubbsJRReversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literatureJ Intensive Care Med20153013725492811
   PubMed Web of Science ®Google Scholar
• CryerBReducing the risks of gastrointestinal bleeding with antiplatelet therapiesN Engl J Med2005352328728915659730
   PubMedGoogle Scholar
• AlgraAMRothwellPMEffects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trialsLancet Oncol201213551852722440112
   PubMed Web of Science ®Google Scholar
• AbnetCCFreedmanNDKamangarFLeitzmannMFHollenbeckARSchatzkinANon-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysisBr J Cancer2009100355155719156150
   PubMedGoogle Scholar
• YeXFuJYangYGaoYLiuLChenSFrequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysisPLoS One201387e7152223936269
   PubMed Web of Science ®Google Scholar